πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 50 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12422364

Fluorescence spectral shape analysis for analyte recognition

The Board of Regents of the University of Texas System Β· Granted Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12410418

Optimized engineered meganucleases having specificity for a recognition sequence in the He

Precision BioSciences, Inc. Β· Granted Tue Sep 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12403134

Method for improving or enhancing cognition

VANDA PHARMACEUTICALS INC. Β· Granted Tue Sep 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12351839

Rationally-designed single-chain meganucleases with non-palindromic recognition sequences

Precision BioSciences, Inc. Β· Granted Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12239694

Methods and compositions for improved cognition

The Regents of the University of California Β· Granted Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12208167

Coated tablets for pH-dependent release of benzgalantamine

ALPHA COGNITION INC. Β· Granted Tue Jan 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12157743

Solid forms of Alpha-1062 gluconate

ALPHA COGNITION INC. Β· Granted Tue Dec 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12110315

Fish-derived peptidoglycan recognition protein mutant and application thereof

OCEAN UNIVERSITY OF CHINA Β· Granted Tue Oct 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12006522

Polynucleotides encoding engineered meganucleases having specificity for recognition seque

Precision BioSciences, Inc. Β· Granted Tue Jun 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11993793

Polynucleotides encoding engineered meganucleases having specificity for recognition seque

Precision BioSciences, Inc. Β· Granted Tue May 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11839650

Universal influenza vaccine targeting virus/host recognition

The Board of Regents of the University of Texas System Β· Granted Tue Dec 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11795176

Solid forms of Alpha-1062 gluconate

ALPHA COGNITION INC. Β· Granted Tue Oct 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11788077

Polynucleotides encoding optimized engineered meganucleases having specificity for a recog

Precision BioSciences, Inc. Β· Granted Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11753630

Polynucleotides encoding engineered meganucleases having specificity for recognition seque

Precision BioSciences, Inc. Β· Granted Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11738070

Methods and compositions for improved cognition

The Regents of the University of California Β· Granted Tue Aug 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11680254

Engineered meganucleases specific for recognition sequences in the PCSK9 gene

Precision BioSciences, Inc. Β· Granted Tue Jun 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11433057

Method for improving or enhancing cognition

VANDA PHARMACEUTICALS INC. Β· Granted Tue Sep 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11274285

Engineered meganucleases specific for recognition sequences in the Hepatitis B virus genom

Precision BioSciences, Inc. Β· Granted Tue Mar 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11266693

Nucleic acids encoding engineered meganucleases with recognition sequences found in the hu

Precision BioSciences, Inc. Β· Granted Tue Mar 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11142750

Optimized engineered meganucleases having specificity for a recognition sequence in the He

Precision BioSciences, Inc. Β· Granted Tue Oct 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11123351

Pharmaceutical formulation of 3-alpha-ethynyl-3-beta-hydroxyandrostan-17-one oxime

Umecrine Cognition AB Β· Granted Tue Sep 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11077108

Allosteric corticotropin-releasing factor receptor 1 (CRFR1) antagonists that decrease p-t

The Regents of the University of California Β· Granted Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10980847

Compositions and methods for detecting and treating brain injury associated fatigue and al

The Board of Regents of the University of Texas System Β· Granted Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10864256

Methods and compositions for improved cognition

The Regents of the University of California Β· Granted Tue Dec 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted